Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
Abstract Background Alzheimer’s disease (AD) is a devastating age-related neurodegenerative disorder and characterized by progressive loss of memory and cognitive functions, which are associated with amyloid-beta (Aβ) plaques. Immune cells play an important role in the clearance of Aβ deposits. Immu...
Guardado en:
Autores principales: | Haiyan Liu, Jin Zhao, Yujun Lin, Min Su, Laijun Lai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9c8535663b54d36a5a6cb72c16bd770 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001) -
Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
por: Shima Mehrabadi, et al.
Publicado: (2021) -
Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020) -
Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity
por: DÍAZ,JUAN CARLOS, et al.
Publicado: (2006) -
Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)